When to tapper atropine in op compound posioning and what is the duration of atropine therapy
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Finding Sources
Searching the Web
atropine tapering protocol organophosphate poisoning duration when to stop
I now have very comprehensive information from multiple authoritative sources. Let me compile the final answer.
Atropine in Organophosphate (OP) Compound Poisoning: When to Taper and Duration of Therapy
Goals of Atropine Therapy
Atropine is a competitive antagonist at muscarinic receptors and is the primary antidote for OP poisoning. It counteracts muscarinic and CNS effects but has no effect on nicotinic receptor sites (i.e., it does not reverse skeletal/respiratory muscle paralysis).
The endpoint of atropinization is:
- Drying of respiratory/bronchial secretions (most important)
- Easing of respiratory effort and normalization of respiratory rate
- Clearing of bronchospasm
- NOT tachycardia or mydriasis alone - these are acceptable side effects and are NOT indications to stop therapy
Initial Dosing (to Achieve Atropinization)
| Severity | Initial Dose | Repeat Interval |
|---|---|---|
| Mild | 2-4 mg IV/IM | Every 20 min |
| Moderate | 2-4 mg IV/IM | Every 10 min |
| Severe | 4-6 mg IV/IM | Every 3-10 min |
- Dose is doubled every 5 minutes until muscarinic effects (especially secretions) are controlled
- Severely poisoned patients may need 200-500 mg in the first hour and 40-50 mg in the first 24 hours on average
- Up to 12 mg can be safely given in the first 6 hours
Once atropinization is achieved, an infusion is started at 10-20% of the total cumulative dose per hour (e.g., if 100 mg was needed to achieve atropinization, run at 10-20 mg/hour).
Signs of Adequate Atropinization (Know These)
- Flushing of face
- Dry mouth and dry, warm skin (key endpoint)
- Blurring of vision
- Dilatation of pupils
- Rapid/irregular pulse
- Loss of neuromuscular coordination
Once these appear, the dose should be adjusted to maintain this effect for at least 24 hours - The Essentials of Forensic Medicine and Toxicology, 36th ed. (2026).
When to Begin Tapering Atropine
Tapering is done based on clinical response, not on a fixed time. Begin to taper when:
- Cholinergic symptoms have been absent for 12-24 hours at the current infusion rate
- Patient is clinically stable - no recurrence of secretions, bronchospasm, bradycardia
- Muscarinic features remain suppressed on a gradually lowered dose
- Pralidoxime (if given concurrently) is also being tapered - oximes are given until the patient is clinically well and not requiring atropine
How to taper:
- Reduce the infusion rate gradually, watching for re-emergence of cholinergic symptoms (increased secretions, bronchospasm, sweating)
- If symptoms return, immediately reinstate the prior dose
- After prolonged use of high doses, atropine must be tapered gradually - abrupt discontinuation can cause rapid pulmonary oedema and respiratory deterioration (P C Dikshit Textbook of Forensic Medicine and Toxicology)
Duration of Atropine Therapy
Duration is entirely dictated by the specific OP compound and severity:
| Scenario | Typical Duration |
|---|---|
| Nerve agents (military/vapor) | 2-3 hours for life-threatening effects; up to 6-36 hours for residual symptoms |
| Mild OP insecticide poisoning | 24-48 hours |
| Moderate OP insecticide poisoning | 2-5 days |
| Severe OP insecticide poisoning | Days to weeks |
| Fat-soluble OP compounds (e.g., fenthion, chlorfenthion) | Weeks to months - ongoing release from fat depots |
| Extreme suicidal ingestion cases | Up to 30-40 days (9-11 g total atropine reported) |
A case report published in 2023 describes 2 months of prolonged atropine therapy for a severe OP poisoning, illustrating that duration depends on the compound's fat-solubility and clinical course.
Key point on fat-soluble OPs: Stopping atropine at a fixed "24 hours after atropinization" rule is dangerous for fat-soluble compounds (e.g., fenthion) because continued release from fat depots can cause recurrent cholinergic toxicity. Duration must be individualized.
If Atropine Toxicity (Over-Atropinization) Develops
Signs: agitation, confusion, hyperthermia, absent bowel sounds, urinary retention, marked tachycardia (>140 bpm), delirium.
Management:
- Stop the infusion and wait 30-60 minutes for symptoms to settle
- Restart at 70-80% of the previous infusion rate
- Control hyperthermia with active cooling (fan, cold sponging) - hyperthermia-induced cardiac arrest is a risk
- Atropine overdose is reversed by physostigmine salicylate (1-2 mg IV/IM in adults, up to 6 mg total; 0.5 mg in children)
Role of Pralidoxime in Reducing Atropine Requirement
Pralidoxime (2-PAM) acts synergistically with atropine and decreases the total amount of atropine required. When both are used together, the atropine dose should be reduced accordingly. Oximes should be started as early as possible (ideally within 24 hours) and continued until the patient is clinically well and no longer requires atropine.
Sources: Rosen's Emergency Medicine, 9e | The Essentials of Forensic Medicine and Toxicology, 36th ed. (2026) | P C Dikshit Textbook of Forensic Medicine and Toxicology | Atlantic Canada Poison Centre - Atropine Monograph | NHRC Management of OP Poisoning Guidelines
This is a shared conversation. Sign in to Orris to start your own chat.